...
首页> 外文期刊>The journal of gene medicine >Construction of X-ray-inducible promoters through cis-acting element elongation and error-prone polymerase chain reaction
【24h】

Construction of X-ray-inducible promoters through cis-acting element elongation and error-prone polymerase chain reaction

机译:通过顺式作用元件延伸和易错聚合酶链反应构建X射线诱导型启动子

获取原文
获取原文并翻译 | 示例

摘要

Background A promoter that is activated by ionizing radiation may be a useful tool for cancer therapy since, with such a promoter, the therapeutic gene can be expressed only in cancer tissues by irradiation. An artificially constructed promoter is advantageous as natural promoters may have physiological limitations. However, reasonably designing a promoter is hampered by shortage of information about the relationship between the structure and properties of a promoter DNA. Materials and methods Binding sites of four transcription factors that were activated by radiation were randomly ligated and linked to a TATA-box sequence to control the luciferase gene located downstream. Transiently transfected cancer cells with such a vector were exposed to X-ray irradiation and enhancement of luciferase expression was assessed. To improve promoter sensitivity, mutations were randomly introduced into a constructed promoter by error-prone polymerase chain reaction (epPCR). Results Of the 11 promoters constructed, the clone 11 promoter (clone 11 + TATA-box) showed a 5-fold enhancement 6 h after the 10 GyX-ray irradiation in HeLa cells. A mutant designated the clone 11-9-37 promoter generated through two steps of epPCR showed a sensitivity 4.8 times higher than the clone 11 promoter to the 10 Gy X-rays, showing 21.6-fold enhancement of luciferase expression. Clone 11 was composed of 16 cis-acting elements, and the clone 11-9-37 promoter carried six point mutations. Conclusion A sensitively responsive promoter to radiation could be constructed using this method, possibly leading to the construction of a promoter of interest that could be applied for clinical use. Copyright (C) 2007 John Wiley & Sons, Ltd.
机译:背景技术通过电离辐射激活的启动子可能是用于癌症治疗的有用工具,因为使用这种启动子,治疗基因只能通过辐射在癌症组织中表达。人工构建的启动子是有利的,因为天然启动子可能具有生理限制。然而,由于缺乏有关启动子DNA的结构和性质之间的关系的信息,妨碍了合理设计启动子。材料和方法将通过辐射激活的四个转录因子的结合位点随机连接并连接到TATA-box序列上,以控制位于下游的荧光素酶基因。将用这种载体瞬时转染的癌细胞暴露于X射线照射,并评估荧光素酶表达的增强。为了提高启动子的敏感性,通过易错聚合酶链反应(epPCR)将突变随机引入构建的启动子中。结果在构建的11个启动子中,克隆11启动子(克隆11 + TATA-box)在HeLa细胞中受到10 GyX射线照射后6 h表现出5倍的增强。通过两步epPCR生成的名为克隆11-9-37启动子的突变体对10 Gy X射线的敏感性比克隆11启动子高4.8倍,显示萤光素酶表达增强了21.6倍。克隆11由16个顺式作用元件组成,克隆11-9-37启动子带有六个点突变。结论使用该方法可以构建对辐射敏感的启动子,可能导致构建可用于临床的目标启动子。版权所有(C)2007 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号